Annual accounts receivable:
$9.99B+$392.79M(+4.09%)Summary
- As of today (September 9, 2025), NVO annual accounts receivable is $9.99 billion, with the most recent change of +$392.79 million (+4.09%) on December 31, 2024.
- During the last 3 years, NVO annual accounts receivable has risen by +$3.78 billion (+60.77%).
- NVO annual accounts receivable is now at all-time high.
Performance
NVO Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$10.95B+$889.94M(+8.85%)Summary
- As of today (September 9, 2025), NVO quarterly accounts receivable is $10.95 billion, with the most recent change of +$889.94 million (+8.85%) on June 1, 2025.
- Over the past year, NVO quarterly accounts receivable has increased by +$1.81 billion (+19.83%).
- NVO quarterly accounts receivable is now at all-time high.
Performance
NVO Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
NVO Accounts receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +4.1% | +19.8% |
3 y3 years | +60.8% | +90.7% |
5 y5 years | +167.0% | +182.8% |
NVO Accounts receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +60.8% | at high | +90.7% |
5 y | 5-year | at high | +167.0% | at high | +185.3% |
alltime | all time | at high | +4800.6% | at high | +2282.9% |
NVO Accounts receivable History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $10.95B(+8.8%) |
Mar 2025 | - | $10.06B(+0.7%) |
Dec 2024 | $9.99B(+4.1%) | $9.99B(+0.7%) |
Sep 2024 | - | $9.93B(+8.7%) |
Jun 2024 | - | $9.14B(+10.7%) |
Mar 2024 | - | $8.25B(-14.0%) |
Dec 2023 | $9.60B(+32.3%) | $9.60B(+28.5%) |
Sep 2023 | - | $7.47B(-16.8%) |
Jun 2023 | - | $8.98B(+21.9%) |
Mar 2023 | - | $7.37B(+1.5%) |
Dec 2022 | $7.26B(+16.8%) | $7.26B(+20.9%) |
Sep 2022 | - | $6.00B(+4.6%) |
Jun 2022 | - | $5.74B(+5.9%) |
Mar 2022 | - | $5.42B(-12.8%) |
Dec 2021 | $6.21B(+36.3%) | $6.21B(+33.5%) |
Sep 2021 | - | $4.65B(+11.8%) |
Jun 2021 | - | $4.16B(-6.0%) |
Mar 2021 | - | $4.43B(-2.8%) |
Dec 2020 | $4.56B(+21.8%) | $4.56B(+18.8%) |
Sep 2020 | - | $3.84B(-0.9%) |
Jun 2020 | - | $3.87B(-12.5%) |
Mar 2020 | - | $4.42B(+18.2%) |
Dec 2019 | $3.74B(+7.2%) | $3.74B(+13.8%) |
Sep 2019 | - | $3.29B(-7.3%) |
Jun 2019 | - | $3.55B(+9.8%) |
Mar 2019 | - | $3.23B(-7.4%) |
Dec 2018 | $3.49B(+7.3%) | $3.49B(+20.9%) |
Sep 2018 | - | $2.89B(-2.9%) |
Jun 2018 | - | $2.97B(+10.3%) |
Mar 2018 | - | $2.70B(-17.1%) |
Dec 2017 | $3.25B(+13.3%) | $3.25B(+19.0%) |
Sep 2017 | - | $2.73B(+2.6%) |
Jun 2017 | - | $2.66B(+8.9%) |
Mar 2017 | - | $2.45B(-14.8%) |
Dec 2016 | $2.87B(+27.3%) | $2.87B(+17.2%) |
Sep 2016 | - | $2.45B(+4.1%) |
Jun 2016 | - | $2.35B(-6.8%) |
Mar 2016 | - | $2.52B(+12.0%) |
Dec 2015 | $2.25B(+6.4%) | $2.25B(+11.1%) |
Sep 2015 | - | $2.03B(-4.4%) |
Jun 2015 | - | $2.12B(+0.8%) |
Mar 2015 | - | $2.11B(-0.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | $2.12B(+5.2%) | $2.12B(+15.5%) |
Sep 2014 | - | $1.83B(-13.2%) |
Jun 2014 | - | $2.11B(+9.3%) |
Mar 2014 | - | $1.93B(-4.0%) |
Dec 2013 | $2.01B(+18.3%) | $2.01B(+14.2%) |
Sep 2013 | - | $1.76B(-7.9%) |
Jun 2013 | - | $1.92B(+5.1%) |
Mar 2013 | - | $1.82B(+7.0%) |
Dec 2012 | $1.70B(+4.3%) | $1.70B(+1.8%) |
Sep 2012 | - | $1.67B(-1.3%) |
Jun 2012 | - | $1.69B(-1.2%) |
Mar 2012 | - | $1.71B(+5.0%) |
Dec 2011 | $1.63B(+6.7%) | $1.63B(+0.0%) |
Sep 2011 | - | $1.63B(-11.0%) |
Jun 2011 | - | $1.83B(+5.6%) |
Mar 2011 | - | $1.74B(+13.5%) |
Dec 2010 | $1.53B(+12.4%) | $1.53B(-1.9%) |
Sep 2010 | - | $1.56B(+9.5%) |
Jun 2010 | - | $1.42B(-3.8%) |
Mar 2010 | - | $1.48B(+24.4%) |
Dec 2009 | $1.36B(+10.8%) | - |
Mar 2009 | - | $1.19B(-9.5%) |
Dec 2008 | $1.23B(+2.9%) | - |
Mar 2008 | - | $1.32B(+144.3%) |
Dec 2007 | $1.19B(+30.8%) | - |
Dec 2006 | $913.30M(+20.5%) | - |
Dec 2005 | $758.13M(+2.1%) | - |
Dec 2004 | $742.25M(+15.1%) | - |
Dec 2003 | $645.08M(+19.8%) | - |
Dec 2002 | $538.40M(+15.8%) | $538.40M(+17.2%) |
Dec 2001 | $464.89M(+8.8%) | $459.38M(-21.7%) |
Dec 2000 | $427.18M(-13.2%) | $587.05M(-20.7%) |
Dec 1999 | $492.30M(-7.9%) | $740.38M(-17.2%) |
Dec 1998 | $534.37M(+3.2%) | $893.87M |
Dec 1997 | $517.86M(-11.6%) | - |
Dec 1996 | $585.53M(+16.2%) | - |
Dec 1995 | $503.79M(+11.6%) | - |
Dec 1994 | $451.57M(+15.5%) | - |
Dec 1993 | $391.12M(+12.9%) | - |
Dec 1992 | $346.39M(+9.3%) | - |
Dec 1991 | $316.86M(+3.3%) | - |
Dec 1990 | $306.81M(+50.5%) | - |
Dec 1989 | $203.87M | - |
FAQ
- What is Novo Nordisk A/S annual accounts receivable?
- What is the all time high annual accounts receivable for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual accounts receivable year-on-year change?
- What is Novo Nordisk A/S quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly accounts receivable year-on-year change?
What is Novo Nordisk A/S annual accounts receivable?
The current annual accounts receivable of NVO is $9.99B
What is the all time high annual accounts receivable for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual accounts receivable is $9.99B
What is Novo Nordisk A/S annual accounts receivable year-on-year change?
Over the past year, NVO annual accounts receivable has changed by +$392.79M (+4.09%)
What is Novo Nordisk A/S quarterly accounts receivable?
The current quarterly accounts receivable of NVO is $10.95B
What is the all time high quarterly accounts receivable for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly accounts receivable is $10.95B
What is Novo Nordisk A/S quarterly accounts receivable year-on-year change?
Over the past year, NVO quarterly accounts receivable has changed by +$1.81B (+19.83%)